GSK plc Published 2019 Annual Report

GSK plc has published its 2019 Annual Report, offering a comprehensive overview of the company's strategy, business model, and financial developments. Operating as a global healthcare company, GSK focuses on scientific and technical expertise to develop medicines, vaccines, and consumer healthcare products.

The report outlines GSK's strategy to deliver differentiated, high-quality, and needed healthcare products to as many people as possible through its three global business units. The company made significant investments in research and development, totaling £4.6 billion in 2019. Scientific focus areas include research related to the immune system, human genetics, and advanced technology.

GSK's business model is centered on discovering, developing, and manufacturing innovative products. The company employs over 99,000 people across 95 countries, leveraging its extensive scientific and technical know-how, alongside deep expertise in regulation, intellectual property, and commercialization. GSK also collaborates with leading experts and forms strategic partnerships.

The report further details the company's values: patient focus, transparency, respect, and integrity. Operational expectations include courage, accountability, development, and teamwork. GSK's overarching goal is to become one of the world's most innovative, best-performing, and trusted healthcare companies.